183 related articles for article (PubMed ID: 36644576)
1. RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway.
Hua H; Xie H; Zheng J; Lei L; Deng Z; Yu C
Oxid Med Cell Longev; 2023; 2023():1728463. PubMed ID: 36644576
[TBL] [Abstract][Full Text] [Related]
2. RNF7 promotes glioma growth via the PI3K/AKT signalling axis.
Tang N; Zhu K; Jiang C; Xiong Z; Wang Q; Li J; Xu W
J Cell Mol Med; 2023 Jan; 27(2):277-286. PubMed ID: 36578229
[TBL] [Abstract][Full Text] [Related]
3. PELI1: key players in the oncogenic characteristics of pancreatic Cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract][Full Text] [Related]
4. Insulin receptor tyrosine kinase substrate (IRTKS) promotes the tumorigenesis of pancreatic cancer via PI3K/AKT signaling.
Lu Y; Zhou XY; Zhou CL; Liu J; Yong T; Fan Y; Wang C
Hum Cell; 2022 Nov; 35(6):1885-1899. PubMed ID: 36057038
[TBL] [Abstract][Full Text] [Related]
5. MZB1 regulates cellular proliferation, mitochondrial dysfunction, and inflammation and targets the PI3K-Akt signaling pathway in acute pancreatitis.
Xu M; Feng Y; Xiang X; Liu L; Tang G
Cell Signal; 2024 Jun; 118():111143. PubMed ID: 38508349
[TBL] [Abstract][Full Text] [Related]
6. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zhu J; Lv J; Chen J; Zhang X; Ji Y
Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959
[No Abstract] [Full Text] [Related]
7. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
8. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
[TBL] [Abstract][Full Text] [Related]
9. Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer.
Wang K; Hao Z; Fu X; Li W; Jiao A; Hua X
Mol Cell Biochem; 2022 Jul; 477(7):1947-1957. PubMed ID: 35362843
[TBL] [Abstract][Full Text] [Related]
10. TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway.
Fu Y; Yao N; Ding D; Zhang X; Liu H; Ma L; Shi W; Zhu C; Tang L
J Cell Physiol; 2020 Mar; 235(3):2761-2775. PubMed ID: 31531884
[TBL] [Abstract][Full Text] [Related]
11. Effect of COP1 in Promoting the Tumorigenesis of Gastric Cancer by Down-Regulation of CDH18 via PI3K/AKT Signal Pathway.
Zhao B; Wu J; Cha X; Mao G; Shi H; Fei S; Miao B
Anal Cell Pathol (Amst); 2023; 2023():5617875. PubMed ID: 37025097
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
13. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer.
Gu J; Huang W; Wang X; Zhang J; Tao T; Zheng Y; Liu S; Yang J; Chen ZS; Cai CY; Li J; Wang H; Fan Y
Mol Cancer; 2022 May; 21(1):112. PubMed ID: 35538494
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
15. SIAH2 regulates colorectal cancer tumorigenesis via PI3K/ATK signaling pathway.
Hu Y; He Y; Liu W; Yu S; Wei Y; Bai S; Su Y; Xiao B
Tissue Cell; 2022 Oct; 78():101878. PubMed ID: 35926257
[TBL] [Abstract][Full Text] [Related]
16. RNF7 Induces Skeletal Muscle Cell Apoptosis and Arrests Cell Autophagy via Upregulation of THBS1 and Inactivation of the PI3K/Akt Signaling Pathway in a Rat Sepsis Model.
Lei Y; Jin X; Sun M; Ji Z
Infect Immun; 2023 Apr; 91(4):e0053522. PubMed ID: 36920202
[TBL] [Abstract][Full Text] [Related]
17. MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1.
Sun Y; Cao FL; Qu LL; Wang ZM; Liu XY
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1459-1467. PubMed ID: 30840267
[TBL] [Abstract][Full Text] [Related]
18. RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop.
Xiao C; Zhang W; Hua M; Chen H; Yang B; Wang Y; Yang Q
Cell Mol Biol Lett; 2022 May; 27(1):36. PubMed ID: 35562668
[TBL] [Abstract][Full Text] [Related]
19. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
[TBL] [Abstract][Full Text] [Related]
20. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
Yu C; Zhang B; Li YL; Yu XR
Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]